Latest Breaking News On - Christine fanelle - Page 2 : vimarsana.com

Paratek Pharmaceuticals Announces Inclusion of NUZYRA® (omadacycline) in China's National Reimbursement Drug List (NRDL)

BOSTON, Jan. 18, 2023 -- Paratek Pharmaceuticals, Inc. today announced that China’s National Healthcare Security Administration has added the intravenous formulation of... | January 18, 2023

Paratek Pharmaceuticals Announces Third Quarter 2022 Revenue of $30.2 Million

Paratek Pharmaceuticals to Host Investor Update on the

Oct. 3 Webinar Features Presentations by Scientific Leaders in NTM and Paratek’s Management Team...

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Paratek Pharmaceuticals to Present at the Jefferies 2022 Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Paratek Pharmaceuticals Announces First Quarter 2022 Revenue of $24.9 Million

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Press release content from Globe Newswire. The AP news staff was not involved in its creation.